Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure [Original Articles]

Conclusions:
Adoption of sacubitril/valsartan after Food and Drug Administration approval has been slow and may be associated with the high cost.

Source: Circulation: Heart Failure - February 16, 2018 Category: Cardiology Authors: Sangaralingham, L. R., Sangaralingham, S. J., Shah, N. D., Yao, X., Dunlay, S. M. Tags: Heart Failure, Health Services Original Articles Source Type: research